These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 20210926)
41. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes. Bradley AJ; Scott MD Am J Hematol; 2007 Nov; 82(11):970-5. PubMed ID: 17654505 [TBL] [Abstract][Full Text] [Related]
42. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood. Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818 [TBL] [Abstract][Full Text] [Related]
43. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus. Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700 [TBL] [Abstract][Full Text] [Related]
44. Alzheimer's disease is associated with low density of the long CR1 isoform. Mahmoudi R; Kisserli A; Novella JL; Donvito B; Dramé M; Réveil B; Duret V; Jolly D; Pham BN; Cohen JH Neurobiol Aging; 2015 Apr; 36(4):1766.e5-1766.e12. PubMed ID: 25666996 [TBL] [Abstract][Full Text] [Related]
45. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients. Kanto T; Hayashi N; Takehara T; Katayama K; Kato M; Akiyama M; Kasahara A; Fusamoto H; Kamada T J Med Virol; 1996 Oct; 50(2):126-34. PubMed ID: 8915878 [TBL] [Abstract][Full Text] [Related]
46. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137 [TBL] [Abstract][Full Text] [Related]
47. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Hashmi G; Shariff T; Zhang Y; Cristobal J; Chau C; Seul M; Vissavajjhala P; Baldwin C; Hue-Roye K; Charles-Pierre D; Lomas-Francis C; Reid ME Transfusion; 2007 Apr; 47(4):736-47. PubMed ID: 17381634 [TBL] [Abstract][Full Text] [Related]
48. No quantitative relationship between CR1 and Lutheran expression on erythrocytes: In(Lu) gene product is not a common regulator of CR1 expression on erythrocytes. Oudin S; Lepennec PY; Dervillez X; Tonye-Libyh M; Tabary T; Philbert F; Bougy F; Reveil B; Pennaforte JL; Rouger P; Cohen JH Exp Clin Immunogenet; 1999; 16(2):72-80. PubMed ID: 10343158 [TBL] [Abstract][Full Text] [Related]
49. Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children. Opi DH; Uyoga S; Orori EN; Williams TN; Rowe JA Genes Immun; 2016 Apr; 17(3):171-8. PubMed ID: 26844958 [TBL] [Abstract][Full Text] [Related]
50. Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria. Tetteh-Quarcoo PB; Schmidt CQ; Tham WH; Hauhart R; Mertens HD; Rowe A; Atkinson JP; Cowman AF; Rowe JA; Barlow PN PLoS One; 2012; 7(4):e34820. PubMed ID: 22506052 [TBL] [Abstract][Full Text] [Related]
52. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene. Cockburn IA; Rowe JA Int J Immunogenet; 2006 Feb; 33(1):17-20. PubMed ID: 16426237 [TBL] [Abstract][Full Text] [Related]
53. The polymorphism of the Knops blood group system among five Chinese ethnic groups. Li Q; Han SS; Guo ZH; Yang Y; Zhou J; Zhu ZY Transfus Med; 2010 Dec; 20(6):369-75. PubMed ID: 20670356 [TBL] [Abstract][Full Text] [Related]
54. Knops blood group haplotypes among distinct Brazilian populations. Covas DT; de Oliveira FS; Rodrigues ES; Abe-Sandes K; Silva WA; Fontes AM Transfusion; 2007 Jan; 47(1):147-53. PubMed ID: 17207243 [TBL] [Abstract][Full Text] [Related]
55. Geographical distribution of complement receptor type 1 variants and their associated disease risk. Lucas Sandri T; Adukpo S; Giang DP; Nguetse CN; Antunes Andrade F; Tong HV; Toan NL; Song LH; Elumalai P; Thangaraj K; Valluri VL; Ntoumi F; Meyer CG; Jose de Messias Reason I; Kremsner PG; Velavan TP PLoS One; 2017; 12(5):e0175973. PubMed ID: 28520715 [TBL] [Abstract][Full Text] [Related]
56. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Herrera AH; Xiang L; Martin SG; Lewis J; Wilson JG Clin Immunol Immunopathol; 1998 May; 87(2):176-83. PubMed ID: 9614933 [TBL] [Abstract][Full Text] [Related]
57. Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon? Ruuska PE; Ikäheimo I; Silvennoinen-Kassinen S; Käär ML; Tiilikainen A Clin Exp Immunol; 1992 Jul; 89(1):18-21. PubMed ID: 1352745 [TBL] [Abstract][Full Text] [Related]
58. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. Cornillet P; Philbert F; Kazatchkine MD; Cohen JH J Immunol Methods; 1991 Feb; 136(2):193-7. PubMed ID: 1671871 [TBL] [Abstract][Full Text] [Related]